VBIV VBI Vaccines, Inc. Net earnings per share growth forecast for next year

Corporate emblem and logo of VBI Vaccines Inc (VBIV)

VBI Vaccines Inc. relies on its proprietary drug development platform, generating steady revenue from the sale of hepatitis B treatments. Innovations in eVLP particles enable the creation of effective brain cancer vaccines with minimal side effects. The consensus for next year's earnings per share change, which this dynamic chart on GURU.Markets displays via the 77.80 metric, determines this level against the backdrop of the business's financial restructuring.

VBIV - VBI Vaccines, Inc. Net earnings per share growth forecast for next year over the range 07/04/2022 - 08/17/2024

VBIV (VBI Vaccines Inc.): analytical breakdowns and indicator data

Fundamental company valuation:VBI Vaccines
Finished products of VBI Vaccines Inc

This indicator measures the percentage change in expected earnings per share for the coming year, reflecting the analysts' consensus forecast on business growth rates. The trend in expected EPS growth for VBI Vaccines Inc. (VBIV) demonstrates the company's ability to overcome R&D costs and competition in the hepatitis B segment, determining the overall investment resilience of the asset.

Key competitors

Expected earnings per share growth for next year GILD|Earnings growth forecast for next year Cidara Therapeutics, Inc.|Net earnings per share growth forecast for next year Novavax Inc (NVAX)|Consensus forecast of earnings per share growth for next year CureVac|Valneva Pharma - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Vir Corp (VIR)|siga.com - Earnings growth forecast for next year|Expected net earnings per share growth next year emergentbiosolutions.com|AVIR: Earnings growth forecast for next year|IVVD (Invivyd Inc) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Enanta Pharmaceuticals|Inovio Pharma (INO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year HLVX|KLRS (Kalaris Therapeutics Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year DYAI (Dyadic International)|Consensus forecast of earnings per share growth for next year NanoViricides, Inc. (NNVC)|TLPH - Net earnings per share growth forecast for next year|Cocrystal - Projected earnings per share increase next year|TRAW: Earnings growth forecast for next year|Dogwood Therapeutics, Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year QLGN|allovir.com (ALVR) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year VIRI|Expected earnings per share growth for next year Vaxart Corp VXRT